XTANT MEDICAL HOLDINGS, INC. Repayments of Lines of Credit
XTANT MEDICAL HOLDINGS, INC. (XTNT) reported Repayments of Lines of Credit of $26.77 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLinesOfCredit · last filed 2026-08-11
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for the quarter ending 2026-06-30 was $14.72M, a 43.18% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for the quarter ending 2026-03-31 was $12.04M, a 53.70% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for the quarter ending 2025-12-31 was $22.94M, a 15.31% decline year-over-year.
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for the quarter ending 2025-09-30 was $26.46M, a 2.71% increase year-over-year.
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for fiscal 2025 was $101.33M, a 3.63% decline from fiscal 2024.
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for fiscal 2024 was $105.14M, a 36.59% increase from fiscal 2023.
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for fiscal 2023 was $76.98M, a 41.32% increase from fiscal 2022.
- XTANT MEDICAL HOLDINGS, INC. repayments of lines of credit for fiscal 2022 was $54.47M, a 49.27% increase from fiscal 2021.
| Period end | Repayments of Lines of Credit 3 month | Repayments of Lines of Credit 6 month | Repayments of Lines of Credit 9 month | Repayments of Lines of Credit 12 month |
|---|---|---|---|---|
| 2026-06-30 | $14.72M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $26.77M 10-Q · filed 2026-08-11 | $49.71M derived: sum of 3 quarters · filed 2026-08-11 | $76.17M derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | $12.04M 10-Q · filed 2026-05-13 | $34.99M derived: sum of 2 quarters · filed 2026-05-13 | $61.45M derived: sum of 3 quarters · filed 2026-05-13 | $87.36M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-12-31 | $22.94M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $49.40M derived: sum of 2 quarters · filed 2026-03-31 | $75.31M derived: sum of 3 quarters · filed 2026-08-11 | $101.33M 10-K · filed 2026-03-31 |
| 2025-09-30 | $26.46M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $52.37M derived: sum of 2 quarters · filed 2026-08-11 | $78.39M 10-Q · filed 2025-11-10 | $105.48M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-06-30 | $25.91M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | $51.92M 10-Q · filed 2026-08-11 | $79.02M derived: sum of 3 quarters · filed 2026-08-11 | $104.78M derived: sum of 4 quarters · filed 2026-08-11 |
| 2025-03-31 | $26.02M 10-Q · filed 2026-05-13 | $53.11M derived: sum of 2 quarters · filed 2026-05-13 | $78.87M derived: sum of 3 quarters · filed 2026-05-13 | $106.36M derived: sum of 4 quarters · filed 2026-05-13 |
| 2024-12-31 | $27.09M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-31 | $52.85M derived: sum of 2 quarters · filed 2026-03-31 | $80.34M derived: sum of 3 quarters · filed 2026-03-31 | $105.14M 10-K · filed 2026-03-31 |
| 2024-09-30 | $25.76M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $53.25M derived: sum of 2 quarters · filed 2025-11-10 | $78.05M 10-Q · filed 2025-11-10 | $100.30M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $27.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | $52.29M 10-Q · filed 2025-08-12 | $74.54M derived: sum of 3 quarters · filed 2025-08-12 | $94.66M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $24.80M 10-Q · filed 2025-05-12 | $47.05M derived: sum of 2 quarters · filed 2025-05-12 | $67.17M derived: sum of 3 quarters · filed 2025-05-12 | $84.90M derived: sum of 4 quarters · filed 2025-05-12 |
| 2023-12-31 | $22.25M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $42.37M derived: sum of 2 quarters · filed 2025-03-06 | $60.10M derived: sum of 3 quarters · filed 2025-03-06 | $76.98M 10-K · filed 2025-03-06 |
| 2023-09-30 | $20.12M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $37.85M derived: sum of 2 quarters · filed 2024-11-12 | $54.72M 10-Q · filed 2024-11-12 | $69.61M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $17.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $34.60M 10-Q · filed 2024-08-08 | $49.49M derived: sum of 3 quarters · filed 2024-08-08 | $62.62M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $16.87M 10-Q · filed 2024-05-15 | $31.76M derived: sum of 2 quarters · filed 2024-05-15 | $44.89M derived: sum of 3 quarters · filed 2024-05-15 | $59.01M derived: sum of 4 quarters · filed 2024-05-15 |
| 2022-12-31 | $14.89M derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-01 | $28.02M derived: sum of 2 quarters · filed 2024-04-01 | $42.14M derived: sum of 3 quarters · filed 2024-04-01 | $54.47M 10-K · filed 2024-04-01 |
| 2022-09-30 | $13.13M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $27.25M derived: sum of 2 quarters · filed 2023-11-14 | $39.58M 10-Q · filed 2023-11-14 | $53.04M derived: sum of 4 quarters · filed 2023-11-14 |
| 2022-06-30 | $14.12M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-01 | $26.45M 10-Q · filed 2023-08-01 | $39.91M derived: sum of 3 quarters · filed 2023-08-01 | $53.93M derived: sum of 4 quarters · filed 2023-08-01 |
| 2022-03-31 | $12.33M 10-Q · filed 2023-05-04 | $25.79M derived: sum of 2 quarters · filed 2023-05-04 | $39.81M derived: sum of 3 quarters · filed 2023-05-04 | |
| 2021-12-31 | $13.46M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $27.48M derived: sum of 2 quarters · filed 2023-03-07 | $36.49M 10-K · filed 2023-03-07 | |
| 2021-09-30 | $14.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $23.03M 10-Q · filed 2022-11-03 | ||
| 2021-06-30 | $9.01M 10-Q · filed 2022-08-04 | |||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-21 | $10.29M derived: sum of 2 quarters · filed 2018-03-30 | $10.45M 10-Q · filed 2017-11-21 | |
| 2017-06-30 | $10.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-03-30 | $10.45M 10-Q · filed 2018-03-30 | ||
| 2017-03-31 | $154.58K 10-Q · filed 2018-03-30 | |||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-21 | $0.00 derived: sum of 2 quarters · filed 2018-03-30 | $0.00 10-Q · filed 2017-11-21 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-03-30 | $0.00 10-Q · filed 2018-03-30 | ||
| 2016-03-31 | $0.00 10-Q · filed 2018-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spectral AI, Inc. (MDAI) | United States | $0.052B | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Sensus Healthcare, Inc. (SRTS) | United States | $0.048B | -3.24 |
| NEPHROS INC (NEPH) | United States | $0.046B | 23.02 |
| SANUWAVE Health, Inc. (SNWV) | United States | $0.041B | 5.47 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| InspireMD, Inc. (NSPR) | $0.033B | ||
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| PAVmed Inc. (PAVM) | United States | $0.031B | -3.00 |